BlackRock, Inc.

Position in COGT — Cogent Biosciences, Inc.

CIK 2012383 New York, NY

Position in COGT

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$671,547,394

+$53,974,813 QoQ

Shares Held

17,352,646

+8.1% QoQ

Ownership

10.0%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

of 321 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 97% Shared 0% None 3%

Healthcare · as of Jun 30, 2026

BlackRock, Inc. holds $85,016,936,299 across 474 Biotechnology names. COGT ranks #31 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	24,109,373	$11,975,848,839
2	REGN	Regeneron Pharmaceuticals, Inc.	9,113,506	$5,682,635,520
3	ALNY	Alnylam Pharmaceuticals, Inc.	10,907,675	$3,283,537,392
4	RVMD	Revolution Medicines, Inc.	13,695,790	$2,564,947,540
5	MRNA	Moderna, Inc.	30,599,409	$2,142,876,602
6	INCY	Incyte Corp	18,032,718	$2,044,188,902
7	CYTK	Cytokinetics Inc	20,094,362	$1,711,838,691
8	ROIV	Roivant Sciences Ltd.	48,236,091	$1,707,075,250

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$671,547,394	17,352,646	+8.1%	Shares	Sole	2026-08-07
2026-06-30	$526,051,538	13,593,063	—	Shares	Sole	2026-07-27
2026-03-31	$617,572,581	16,045,014	+23.7%	Shares	Sole	2026-05-13
2025-12-31	$460,857,464	12,974,591	+25.1%	Shares	Sole	2026-02-12
2025-09-30	$148,906,518	10,369,535	+20.2%	Shares	Sole	2025-11-12
2025-06-30	$61,938,846	8,626,581	+5.5%	Shares	Sole	2025-08-12
2025-03-31	$48,971,401	8,175,527	-2.0%	Shares	Sole	2025-05-02
2024-12-31	$65,045,928	8,339,222	+4.4%	Shares	Sole	2025-02-07
2024-09-30	$86,309,136	7,991,587	—	Shares	Sole	2024-11-13
No filing history on record for this holder in this stock.